Literature DB >> 23637507

High Prevalence of Hepatitis C virus Among Injection Drug Users in Zhenjiang, Jiangsu, China.

Nana Wu1, Qinjuan Ge, Qingchuan Feng, Jun Zhang, Xiaoxia Liu, Caihong Sun, Yongkang Xu, Guangli He, Chiyu Zhang.   

Abstract

The constant increase in the number of drug users and rapidly spread of Hepatitis C virus (HCV) and Human immunodeficiency virus (HIV) among drug users result in a serious public health problem in China. To investigate HCV prevalence among drug users in Zhenjiang city, Jiangsu, China, 207 drug users from Zhenjiang were enrolled in this study during 2009 and the prevalence of HCV, HIV and syphilis infection were detected. HCV prevalence among injection drug users (IDUs) was 81.6%, significantly higher than that (22.9%) among oral drug users (P < 0.001), suggesting a strong association of HCV infection with injection drug use (IDU). Most drug users were more than 25 years old (89.2%), single (60.5%, including single and divorced/widowed), and had a history of drug abuse over 6 years (92.9%). HCV prevalence among drug users with middle (72.6%) or high (83.8%) school diplomas was significantly higher than that among those with lower (46.9%) education level (P = 0.007). HCV prevalence among IDUs did not obviously change along with the increase in duration of drug use and in frequency of injection per day, suggesting less association of HCV infection with both variables. These results suggest that most Chinese addicts might start drug use after their middle/high school education. To reduce drug use and to prevent HIV and HCV transmission via IDU, large-scale drug prevention educations should be urgently conducted in all China's middle and high schools.

Entities:  

Keywords:  Education level; HCV; Injection drug use (IDU); Jiangsu; Middle and high school

Year:  2011        PMID: 23637507      PMCID: PMC3550738          DOI: 10.1007/s13337-011-0041-4

Source DB:  PubMed          Journal:  Indian J Virol        ISSN: 0970-2822


  27 in total

Review 1.  Transfusion safety in developing countries and the Indian scenario.

Authors:  V L Ray; R K Chaudhary; N Choudhury
Journal:  Dev Biol (Basel)       Date:  2000

Review 2.  Blood banking in China.

Authors:  Hua Shan; Jing-Xing Wang; Fu-Rong Ren; Yuan-Zhi Zhang; Hai-Yan Zhao; Guo-Jing Gao; Yang Ji; Paul M Ness
Journal:  Lancet       Date:  2002-11-30       Impact factor: 79.321

3.  Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.

Authors:  J A Hahn; K Page-Shafer; P J Lum; K Ochoa; A R Moss
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

4.  Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.

Authors:  M H Elghouzzi; F Bouchardeau; J Pillonel; E Boiret; C Tirtaine; V Barlet; P Moncharmont; P Maisonneuve; M C du Puy-Montbrun; D Lyon-Caen; A M Couroucé
Journal:  Vox Sang       Date:  2000       Impact factor: 2.144

5.  Estimated risk of HIV transmission by blood transfusion in Kenya.

Authors:  A Moore; G Herrera; J Nyamongo; E Lackritz; T Granade; B Nahlen; A Oloo; G Opondo; R Muga; R Janssen
Journal:  Lancet       Date:  2001-08-25       Impact factor: 79.321

6.  Risk factors, clinical features and genotype distribution of diagnosed hepatitis C virus infections: a pilot for a sentinel laboratory-based surveillance.

Authors:  M A Balogun; H Laurichesse; M E Ramsay; J Sellwood; D Westmoreland; W K Paver; S F Pugh; M Zuckerman; D Pillay; T Wreghitt
Journal:  Commun Dis Public Health       Date:  2003-04

Review 7.  Systematic review of HIV and HCV infection among drug users in China.

Authors:  Y-P Bao; Z-M Liu
Journal:  Int J STD AIDS       Date:  2009-06       Impact factor: 1.359

8.  Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum.

Authors:  O Dalgard; S Jeansson; K Skaug; N Raknerud; H Bell
Journal:  Scand J Gastroenterol       Date:  2003-08       Impact factor: 2.423

9.  Epidemiology of hepatitis C virus (HCV) infection.

Authors:  Theodore Sy; M Mazen Jamal
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

10.  Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications.

Authors:  Han-Zhu Qian; Joseph E Schumacher; Huey T Chen; Yu-Hua Ruan
Journal:  Harm Reduct J       Date:  2006-02-01
View more
  2 in total

Review 1.  A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan.

Authors:  Heather Bennett; Nathalie Waser; Karissa Johnston; Jia-Horng Kao; Young-Suk Lim; Zhong-Ping Duan; Youn-Jae Lee; Lai Wei; Chien-Jen Chen; William Sievert; Yong Yuan; Hong Li
Journal:  Hepatol Int       Date:  2015-06-13       Impact factor: 6.047

2.  Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors.

Authors:  Zary Nokhodian; Marjan Meshkati; Peyman Adibi; Behrooz Ataei; Nazila Kassaian; Majid Yaran; Parisa Shoaei; Razieh Hassannejad
Journal:  Int J Prev Med       Date:  2012-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.